Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
If fasting worsens your symptoms or impacts your workouts, recovery, or day-to-day function, its okay to stop
A class action treats many similar claims as one case with a shared outcome, while a multi-district litigation (MDL) groups similar lawsuits for efficiency but keeps each case separate
Click below to request a team member reach out and help you get started, or call us directly at 650.241.6599
Retatrutide (LY3437943) is an investigational medicinal product (IMP) a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors currently under clinical evaluation for obesity and metabolic disease
Six Phase I/II clinical trials enrolling approximately 900 participants confirmed an excellent safety profile with no serious adverse events attributed to the compound
Store in a dry, cool and shaded place
US$ 27.02
US$ 29.06
US$ 25.21
US$ 29.20
US$ 28.66
US$ 23.08
US$ 24.95
